| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,359,363 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$66,817,571 |
|
|
| Total
Shares |
11,359,363 |
|
|
| Total
Value |
$66,817,571 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
5
|
|
Stock
price went up :
|
64
|
3
|
| Stock
price went down : |
59
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.5
|
| Percentage
Gain/Loss : |
 14.2%
|
 -54.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-17 |
126,050 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-07-20 |
4 |
B |
$8.08 |
$41,192 |
I/I |
5,100 |
99,167 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-07-22 |
4 |
B |
$8.02 |
$41,709 |
I/I |
5,200 |
100,200 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-12-30 |
4 |
S |
$2.71 |
$41,949 |
I/I |
(15,473) |
130,000 |
0 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-08-16 |
4 |
B |
$8.10 |
$42,285 |
I/I |
5,221 |
120,217 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-04 |
4 |
B |
$6.50 |
$42,621 |
I/I |
6,557 |
100,557 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-01-28 |
4 |
B |
$6.89 |
$43,686 |
I/I |
6,343 |
150,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-04-12 |
4 |
B |
$2.48 |
$44,827 |
I/I |
18,098 |
325,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-28 |
4 |
B |
$6.36 |
$45,090 |
I/I |
7,091 |
115,500 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-01-20 |
4 |
B |
$2.25 |
$47,952 |
I/I |
21,312 |
310,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-16 |
4 |
B |
$6.41 |
$48,485 |
I/I |
7,563 |
103,710 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-05-21 |
4 |
B |
$4.66 |
$49,338 |
I/I |
10,596 |
120,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-06 |
4 |
B |
$2.26 |
$51,474 |
I/I |
22,733 |
242,507 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-28 |
4 |
B |
$2.63 |
$52,950 |
I/I |
20,125 |
285,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-01-19 |
4 |
B |
$2.24 |
$53,080 |
I/I |
23,688 |
308,688 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-15 |
4 |
B |
$2.43 |
$53,287 |
I/I |
21,964 |
252,675 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-09-23 |
4 |
B |
$7.99 |
$54,393 |
I/I |
6,804 |
122,551 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-06-04 |
4 |
B |
$5.79 |
$57,861 |
I/I |
10,000 |
2,550,000 |
1.5 |
% |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2020-01-02 |
4 |
B |
$3.90 |
$58,508 |
I/I |
15,000 |
4,918,500 |
1.5 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-16 |
4 |
S |
$4.86 |
$60,472 |
I/I |
(12,438) |
85,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-17 |
4 |
B |
$6.98 |
$63,644 |
I/I |
9,118 |
101,647 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-09-14 |
4 |
B |
$3.98 |
$66,068 |
I/I |
16,600 |
130,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-05-22 |
4 |
B |
$5.02 |
$69,589 |
I/I |
13,804 |
125,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-07-21 |
4 |
B |
$7.60 |
$69,933 |
I/I |
9,206 |
145,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-01-21 |
4 |
B |
$2.19 |
$76,811 |
I/I |
35,000 |
315,000 |
1.5 |
% |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2019-12-30 |
4 |
B |
$3.97 |
$79,410 |
I/I |
20,000 |
207,500 |
1.5 |
- |
|
158 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
